Dr. Faustman Diabetes Clinical Trials
The Faustman Lab's clinical trial is currently testing whether using Bacillus Calmette-Guérin (BCG), a generic drug that temporarily elevates TNF levels in the body, will reduce or eliminate autoimmune T cells in patients with type 1 diabetes.
Source: http://www.faustmanlab.org/clinicaltrial/clinicalt.html
Subscribe To
Posts
Comments
No comments:
Post a Comment